Long non-coding RNAs (lncRNAs), which are involved in the regulation of RNA methylation,
can be used to evaluate tumor prognosis. lncRNAs are closely related to the prognosis of …

Background Prognostic assessment is imperative for clinical management of patients with
hepatocellular carcinoma (HCC). Most reported prognostic signatures are based on risk …

Liver cancer is still one of the leading causes of cancer‐related death worldwide. This study
is dedicated to developing a multi–long noncoding RNA (lncRNA) model for risk stratification …

Pancreatic cancer is a highly aggressive disease with poor prognosis. N6-methyladenosine
(m6A) is critical for post-transcriptional modification of messenger RNA (mRNA) and long …

Background Increasing studies have demonstrated the biological function of RNA N6-
methyladenosine (m6A) modifications in tumorigenesis. However, the potential role of m6A …

Abstract Background N6‐methyladenosine (m6A) mediates RNA modification in various
biological processes. It plays a key role in hepatocellular carcinoma (HCC) through …

Colon adenocarcinoma (COAD) is a prevalent malignant tumor that severely threatens
human health across the globe. Immunotherapy is an essential need for patients with COAD …

Purpose. The long noncoding RNAs (lncRNAs) play the important role in tumor occurrence
and progression, and the epithelial to mesenchymal transition (EMT) is the critical process …

Background The global burden of hepatocellular carcinoma (HCC) is increasing, negatively
impacting social health and economies. The discovery of novel and valuable biomarkers for …

Abstract Background N6-Methyladenosine (m6A) RNA modification is the most prevalent
internal modification pattern in eukaryotic mRNAs and plays critical roles in diverse …